US OptionsDetailed Quotes
PSNL250516C7500
- 0.05
- 0.000.00%
15min DelayClose Apr 28 16:00 ET
0.05High0.05Low
0.05Open0.05Pre Close1 Volume0 Open Interest7.50Strike Price5.00Turnover195.59%IV101.33%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier17DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0806Delta0.0932Gamma75.00Leverage Ratio-0.0067Theta0.0001Rho6.04Eff Leverage0.0012Vega
Personalis Stock Discussion
Breakthrough: New Cancer Blood Test Detects Colorectal Relapses Months Before Imaging
Groundbreaking Cancer Detection Test Achieves Major Clinical Milestone: Results From 15+ Cancer Types
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you...
Benzinga· just
Personalis, Inc. (NASDAQ:PSNL), in collaboration with Professor Nick Turner, Dr. Isaac Garcia-Murillas and their colleagues at The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust in the UK, published results from their early-stage breast cancer study in Annals of Oncology. In this groundbreaking study, the authors highlight ad...
has options
$Personalis (PSNL.US)$
nfa
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you don’t a...
No comment yet